Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03366584Phase 4Unknown
Phase 4, randomised, open-label trial (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Hyaline Membrane Disease at 1.5 years. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03366584.